3B ), and treatment beginning on days 22 or 30 showed a trend toward increased RGC survival.
← all excerpts
Intranasal Delivery of A Novel Amnion Cell Secretome Prevents Neuronal Damage and Preserves Function In A Mouse Multiple Sclerosis Model.
1
—
—